Free Energy Landscape for Alpha-Helix to Beta-Sheet Interconversion in Small Amyloid Forming Peptide under Nanoconfinement
- 25 September 2018
- journal article
- research article
- Published by American Chemical Society (ACS) in The Journal of Physical Chemistry B
- Vol. 122 (42) , 9654-9664
Abstract
Understanding the mechanism of fibrilization of amyloid forming peptides could be useful for the development of therapeutics for Alzheimer disease (AD). Taking this standpoint, we have explored in this work the free energy profile for the inter-conversion of monomeric and dimeric forms of amyloid forming peptides into different secondary structures namely beta-sheet, helix and random coil in aqueous solution using umbrella sampling simulations and density functional theory calculations. We show that the helical structures of amyloid peptides can form beta sheet rich aggregates through random coil conformations in aqueous condition. Recent experiments (Chemistry. 2018, 24, 3397-3402 and ACS Appl. Mater. Interfaces, 2017, 9, 21116–21123) show that Molybdenum disulphide nanosurface and nanoparticles can reduce the fibrilization process of amyloid beta peptides. We have unravelled the free energy profile for the inter-conversion of helical forms of amyloid forming peptides into beta-sheet and random coil in the presence of a two dimensional nanosurface of (MoS2). Results indicate that the monomer and dimeric forms of the peptides adopt the random coil conformation in the presence of MoS2 while the helical form is preferable for the monomeric form and that the beta-sheet and helix forms are the preferable forms for dimers in aqueous solution. This is due to strong interaction with MoS2 and intra-molecular hydrogen bonds of random coil conformation. The stabilization of random coil conformation does not lead to beta sheet like secondary structure for aggregate. Thus the confinement of MoS2 promotes deaggregation of amyloid beta peptides rather than aggregation, something that could be useful for the development of therapeutics for AD.Keywords
Funding Information
- Stockholms L?ns Landsting
- Stiftelsen f?r?Strategisk Forskning
This publication has 60 references indexed in Scilit:
- The Ongoing Search for Small Molecules to Study Metal-Associated Amyloid-β Species in Alzheimer’s DiseaseAccounts of Chemical Research, 2014
- Huntington's disease: from molecular pathogenesis to clinical treatmentThe Lancet Neurology, 2011
- REVIEW: Curcumin and Alzheimer's DiseaseCNS Neuroscience & Therapeutics, 2010
- Molecular mechanism of Thioflavin-T binding to amyloid fibrilsBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2010
- Protein Aggregation in the Brain: The Molecular Basis for Alzheimer’s and Parkinson’s DiseasesMolecular Medicine, 2008
- Alterations of some membranetransportproteins in Alzheimer's disease: role of amyloid β-peptideMolecular BioSystems, 2007
- Trehalose alleviates polyglutamine-mediated pathology in a mouse model of Huntington diseaseNature Medicine, 2004
- The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to TherapeuticsScience, 2002
- Biology of Aβ Amyloid in Alzheimer's DiseaseNeurobiology of Disease, 1997
- The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptorNature, 1987